MedTrace Logo

Epidemiologic Study of Persistent Polyclonal B-cell Lymphocytosis (PPBL)

NCT03296046 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2017-09-28

No results posted yet for this study

Summary

The main purpose of this study is the description of all French cases of PPBL and the establishment of minimal criteria for the pathology diagnosis and its follow-up.

The secondary objective is the immunologic and genetic characterization of lymphoid cells causing the disease.

Conditions

  • Persistent Polyclonal B-Cell Lymphocytosis

Interventions

BIOLOGICAL

Blood test

30 ml

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-13
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03296046 on ClinicalTrials.gov